Grants / Department of Defense / Defense Health Agency Contracting Activity - DHACA

W81XWH-21-PCRP-HEROICA: DoD Prostate Cancer, Health Equity Research and Outcomes Improvement Consortium Award

Closed Closed August 4, 2021 Opportunity W81XWH-21-PCRP-HEROICA ☆ Save

This grant is closed. A newer notice from the same program is open now: DoW Breast Cancer, Clinical Research Extension Award (HT942526BCRPCREA2). Status: Closes November 18, 2026 (11 days left). It is in our archive of Defense Health Agency Contracting Activity - DHACA notices from 2021.

• Total funding$13.0 million
• Expected awards3
• Cost sharingNot required
• Funding typeCooperative Agreement, Grant

Key dates

Who can apply

This opportunity was open to any type of organization.

• Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

• Most of the program's money (59% over five years) went to colleges and universities.
• No cost sharing or match is required.

What the grant funds

The FY21 PCRP Health Equity Research and Outcomes Improvement Consortium (HEROIC) Award supports a synergistic, multi-institutional collaboration incorporating innovative and translational approaches that have the potential to make a major impact on specific FY21 PCRP Overarching Challenges. Therefore, all applications are required to address one or both of the following FY21 PCRP Overarching Challenges: • Improve quality of life to enhance outcomes and overall health and wellness for those impacted by prostate cancer Applications should aim to understand the impact of prostate cancer on quality of life for the cancer survivor, their family, caregivers, and their community with the goal of improving and enhancing quality of life and overall health and wellness. Studies should consider both short- and long-term quality of life outcomes. Areas of particular interest include: o The mental and emotional health of patients and their families/caregivers o Impact of quality of life considerations on decision-making after diagnosis and/or treatment o Identification of vulnerable groups of men and their families at great risk of quality of life detriments o Translation of factors or interventions that improve quality of life outcomes and overall health and wellness • Advance Health Equity and Reduce Disparities in Prostate Cancer Applications must be directly relevant to the better understanding and/or reduction of inequities and disparities that impact a person, their family, or their caregiver's ability to prevent, detect, manage, and survive prostate cancer. Inequities may arise from socioeconomic status, race or ethnicity, geography, environment, lifestyle, sexual and/or gender identification, access to care (in rural or urban settings), or other factors. Health inequities may include physical, mental, or emotional health differences, as well as social and financial differences experienced primarily in high-risk or underserved prostate cancer patients. High-risk populations include, but are not limited to, people of African descent (including Caribbean), genetically predisposed populations, Service Members, and Veterans. Underserved populations include, but are not limited to, men with limited access to clinical care and resources (in rural or urban settings), and sexual and/or gender minorities.

Category: Science and Technology and other Research and Development.

Applying now

This notice no longer takes applications. Apply under the newer notice, HT942526BCRPCREA2, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.